載入...
Predicting treatment outcome in classical Hodgkin lymphoma: genomic advances
Classical Hodgkin lymphoma is considered a highly curable disease; however, 20% of patients cannot be cured with standard first-line chemotherapy and have a dismal outcome. Current clinical parameters do not allow accurate risk stratification, and personalized therapies are lacking. In fact, Hodgkin...
Na minha lista:
| Main Authors: | , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2011
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3129642/ https://ncbi.nlm.nih.gov/pubmed/21542892 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/gm240 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|